3-5
2026
影响因子区间
126天
平台估算
8%
2025
中国作者发文占比
—
收费
期刊简介:Regulatory Toxicology and Pharmacology publishes peer reviewed articles that involve the generation, evaluation, and interpretation of experimental animal and human data that are of direct importance and relevance for regulatory authorities with respect to toxicological and pharmacological regulations in society. All peer-reviewed articles that are published should be devoted to improve the protection of human health and environment. Reviews and discussions are welcomed that address legal and/or regulatory decisions with respect to risk assessment and management of toxicological and pharmacological compounds on a scientific basis. It addresses an international readership of scientists, risk assessors and managers, and other professionals active in the field of human and environmental health.Types of peer-reviewed articles published:-Original research articles of relevance for regulatory aspects covering aspects including, but not limited to:1.Factors influencing human sensitivity2.Exposure science related to risk assessment3.Alternative toxicological test methods4.Frameworks for evaluation and integration of data in regulatory evaluations5.Harmonization across regulatory agencies6.Read-across methods and evaluations-Contemporary Reviews on policy related Research issues-Letters to the Editor-Guest Editorials (by Invitation)
【译文】《监管毒理学与药理学》发表同行评审的文章,涉及生成、评估和解释实验动物和人类数据,这些数据对监管机构在社会中的毒理学和药理学法规具有直接的重要性和相关性。所有发表的同行评审文章都应致力于提高人类健康和环境的保护。欢迎就基于科学的风险评估和管理毒理学和药理学化合物的法律和/或监管决策进行评论和讨论。它面向国际读者,包括科学家、风险评估和管理人员以及活跃在人类和环境健康领域的其他专业人士。发表的同行评审文章类型包括:1.与监管方面相关的原始研究文章,包括但不限于:1)影响人类敏感性的因素;2)与风险评估相关的暴露科学;3)替代毒理学测试方法;4)评估和整合监管评估中数据的框架;5)监管机构之间的协调;6)跨读方法与评估;-当代关于政策相关研究问题的评论;-编者来信;-特邀评论员文章(邀请制)

| 指标 | 当前值 | 近三年趋势 |
|---|---|---|
| JCR分区 | Q1 | 暂无 |
| 影响因子区间 | 3-5 | 暂无 |